Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

331 ARTÍCULOS , VIENDO DEL 136 AL 150

Nicotinic Cholinergic Mechanisms in Alzheimer's Disease

Shen J, Wu J.

Int Rev Neurobiol. 2015;124:275-92. doi: 10.1016/bs.irn.2015.08.002. Epub 2015 Sep 26.

Restoring calcium homeostasis to treat Alzheimer's disease: a future perspective

Popugaeva E, Vlasova OL, Bezprozvanny I.

Neurodegener Dis Manag. 2015 Oct;5(5):395-8. doi: 10.2217/nmt.15.36. Epub 2015 Oct 19.

Developments and new vistas in the field of melanocortins

Leone S, Noera G, Bertolini A.

Biomol Concepts. 2015 Dec;6(5-6):361-82. doi: 10.1515/bmc-2015-0023.

The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review

Sheng C, Peng W, Xia ZA, Wang Y, Chen Z, Su N, Wang Z.

BMC Complement Altern Med. 2015 Oct 24;15:386. doi: 10.1186/s12906-015-0894-y.

No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial

Phillips MA, Childs CE, Calder PC, Rogers PJ.

Int J Mol Sci. 2015 Oct 16;16(10):24600-13. doi: 10.3390/ijms161024600.

Benefits and risks of add-on therapies for Alzheimer's disease

Magierski R, Sobow T.

Neurodegener Dis Manag. 2015 Oct;5(5):445-62. doi: 10.2217/nmt.15.39. Epub 2015 Oct 30.

Memantine ER/Donepezil: A Review in Alzheimer's Disease

Greig SL.

CNS Drugs. 2015 Nov;29(11):963-70. doi: 10.1007/s40263-015-0287-2.

Amyloid Fibres: Inert End-Stage Aggregates or Key Players in Disease?

Tipping KW, van Oosten-Hawle P, Hewitt EW, Radford SE.

Trends Biochem Sci. 2015 Dec;40(12):719-727. doi: 10.1016/j.tibs.2015.10.002. Epub 2015 Nov 2.

The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-β Production in Alzheimer's Disease

Zuo L, Hemmelgarn BT, Chuang CC, Best TM.

Oxid Med Cell Longev. 2015;2015:604658. doi: 10.1155/2015/604658. Epub 2015 Oct 12.

Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease

Wicke K, Haupt A, Bespalov A.

Expert Opin Investig Drugs. 2015;24(12):1515-28. doi: 10.1517/13543784.2015.1102884. Epub 2015 Nov 7.

Basic aspects in selecting a suitable transgenic rodent model for Alzheimer's disease

Balmus IM, Ciobica A, Negura A, Negura L, Anton E.

Psychiatr Danub. 2015 Dec;27(4):338-45.

Current and Future Treatments for Alzheimer Disease

Small GW, Greenfield S.

Am J Geriatr Psychiatry. 2015 Nov;23(11):1101-5. doi: 10.1016/j.jagp.2015.08.006. Epub 2015 Sep 9.

Real-world evaluation of compliance and preference in Alzheimer's disease treatment

Pai MC, Aref H, Bassil N, Kandiah N, Lee JH, Srinivasan AV, diTommaso S, Yuksel O.

Clin Interv Aging. 2015 Nov 3;10:1779-87. doi: 10.2147/CIA.S85319. eCollection 2015.

Herbal medicine Davaie Loban in mild to moderate Alzheimer's disease: A 12-week randomized double-blind placebo-controlled clinical trial

Tajadini H, Saifadini R, Choopani R, Mehrabani M, Kamalinejad M, Haghdoost AA.

Complement Ther Med. 2015 Dec;23(6):767-72. doi: 10.1016/j.ctim.2015.06.009. Epub 2015 Aug 29.

Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials

O'Regan J, Lanctôt KL, Mazereeuw G, Herrmann N.

J Clin Psychiatry. 2015 Nov;76(11):e1424-31. doi: 10.4088/JCP.14r09237.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias